Ciproflox-dexameth otic susp 7.5ML
Ended Awarded
- Contract number
- SPE2DB25FQMU6
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,379
Award facts
- Contract value 100% obligated
- $2,378.90 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,378.90 to AmerisourceBergen Drug Corp for the supply of Ciprofloxacin-Dexamethasone Otic Suspension (7.5 mL) on August 5, 2025, with an ultimate completion date of August 6, 2025. This competitively awarded, firm fixed-price contract utilizes no set-aside provisions and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive vehicle for pharmaceutical and medical supply provision across multiple therapeutic domains.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, maintains a significant portfolio of federal medical procurement contracts, particularly with the DLA Medical Supply Chain and Defense Health Agency. The company's extensive experience fulfilling competitive federal procurements for pharmaceuticals, medical devices, and specialized healthcare commodities across varying order values demonstrates its established capability to meet military and veteran healthcare system requirements. This otic suspension delivery supports the DLA's mission to supply critical pharmaceutical products for military medical operations and healthcare delivery systems.
Quick answers
Who was awarded contract SPE2DB25FQMU6?
SPE2DB25FQMU6 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 5, 2025.
How much is contract SPE2DB25FQMU6 worth?
The government has obligated $2,379 on SPE2DB25FQMU6.
Is contract SPE2DB25FQMU6 an order under another contract?
Yes. SPE2DB25FQMU6 is a delivery order under SPE2DB20D7059, an indefinite delivery contract.
Was contract SPE2DB25FQMU6 competed?
The extent of competition for SPE2DB25FQMU6 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award